Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × Specimen Handling × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 48 Lung Neoplasms 45 Neoplasm Metastasis 38 Carcinoma, Non-Small-Cell Lung 38 Leukemia, Myeloid, Acute 36 Colorectal Neoplasms 27 Multiple Myeloma 25 Breast Neoplasms 21 Ovarian Neoplasms 20 Melanoma 19 Pancreatic Neoplasms 18 Triple Negative Breast Neoplasms 16 Carcinoma, Renal Cell 16 Urinary Bladder Neoplasms 15 Carcinoma, Hepatocellular 15 Squamous Cell Carcinoma of Head and Neck 14 Lymphoma, Large B-Cell, Diffuse 14 Glioblastoma 14 Endometrial Neoplasms 14 Mouth Neoplasms 13 Myelodysplastic Syndromes 12 Laryngeal Neoplasms 12 Fallopian Tube Neoplasms 12 Carcinoma 12 Burkitt Lymphoma 12 Oropharyngeal Neoplasms 11 Leukemia, Lymphocytic, Chronic, B-Cell 11 Hypopharyngeal Neoplasms 11 Lymphoma 10 Glioma 9

Interventions

Cisplatin 8 Pemetrexed 7 Carboplatin 4 Platinum 3 Nivolumab 3 Ipilimumab 3 1,2-diaminocyclohexaneplatinum II citrate 3 tremelimumab 2 pembrolizumab 2 durvalumab 2 Cyclophosphamide 2 methoxyamine 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 cediranib 1 bintrafusp alfa protein, human 1 atezolizumab 1 aldesleukin 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 Pharmaceutical Preparations 1 Interleukin-2 1 In Situ Hybridization, Fluorescence 1 Imprint II 1 Immunoglobulin G 1 Gemcitabine 1 Etoposide 1 Disulfides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡